English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  50986591    線上人數 :  757
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"su t h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 6-15 / 608 (共61頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-09T04:21:39Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:38Z Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:32Z Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7) Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:27Z Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:25Z Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study Papatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; Liu C.-J.; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; JIA-HORNG KAO; Hadziyannis S.; Papatheodoridis G.V.
臺大學術典藏 2022-09-09T04:21:22Z Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents Huang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2022-09-09T04:21:21Z Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:20Z Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities Hsu Y.-C.; Tseng C.-H.; Su T.-H.; JIA-HORNG KAO; Nguyen M.H.
臺大學術典藏 2022-09-09T04:21:19Z Paradigm shift in the treatment options of hepatocellular carcinoma Su T.-H.; Hsu S.-J.; JIA-HORNG KAO
臺大學術典藏 2022-09-09T04:21:18Z Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma Wang S.-Y.; Su T.-H.; Chen B.-B.; Liu C.-J.; Liu C.-H.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO

顯示項目 6-15 / 608 (共61頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目